Expression of PD-1 and PD-L1 in anaplastic thyroid cancer patients treated with multimodal therapy: results from a retrospective study.

Conclusion: PD-1/PD-L1 pathway proteins are highly expressed in ATC tumor samples and appear to represent predictive markers of PFS and OS in multimodality-treated ATC patients.
PMID: 28324060 [PubMed - as supplied by publisher]

Source: The Journal of Clinical Endocrinology and Metabolism - March 7, 2017 Category: Endocrinology Authors: Chintakuntlawar AV, Rumilla KM, Smith CY, Jenkins SM, Foote RL, Kasperbauer JL, Morris JC, Ryder M, Alsidawi S, Hilger C, Bible KC Tags: J Clin Endocrinol Metab Source Type: research